South Africa: National AIDS conference opens
Author: U.N. Integrated Regional Information Networks, Published on: 4 August 2003
South Africa's Medicines Control Council is investigating the clinical trials of nevirapine in Uganda, after procedural flaws led to drug company Boehringer-Ingelheim withdrawing an application to have it approved in the United States.
Related companies: Boehringer Ingelheim